UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 360

Sortiert nach

A novel flap design technique for subtotal tongue reconstruction with an “Individualized and Convenient Tongue Model”

Oral oncology, 2023-10, Vol.145, p.106531-106531, Article 106531

2023

Volltextzugriff (PDF)

Risk of venous thromboembolic events associated with VEGFR‐TKIs: A systematic review and meta‐analysis

International journal of cancer, 2013-06, Vol.132 (12), p.2967-2974

2013

Volltextzugriff (PDF)

Reconstruction of large defects of anterior floor of mouth with free flaps using a novel individualized flap design method

Journal of cranio-maxillo-facial surgery, 2023-09, Vol.51 (9), p.574-579

2023

Volltextzugriff (PDF)

Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta‐analysis of clinical trials

British journal of clinical pharmacology, 2013-04, Vol.75 (4), p.919-930

2013

Volltextzugriff (PDF)

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis

PloS one, 2013-06, Vol.8 (6), p.e65166

2013

Volltextzugriff (PDF)

Upregulated miR‑20a‑5p expression promotes proliferation and invasion of head and neck squamous cell carcinoma cells by targeting of TNFRSF21

Oncology reports, 2018-08, Vol.40 (2), p.1138-1146

2018

Volltextzugriff (PDF)

Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression

Acta pharmacologica Sinica, 2016-04, Vol.37 (4), p.519-529

2016

Volltextzugriff (PDF)

Pterostilbene suppresses human endometrial cancer cells in vitro by down-regulating miR-663b

Acta pharmacologica Sinica, 2017-10, Vol.38 (10), p.1394-1400

2017

Volltextzugriff (PDF)

Overall survival benefits for combining targeted therapy as second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of published data

PloS one, 2013-02, Vol.8 (2), p.e55637-e55637

2013

Volltextzugriff (PDF)

Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells

BMC cancer, 2016-10, Vol.16 (1), p.818-818, Article 818

2016

Volltextzugriff (PDF)

p21-activated kinase 7 is an oncogene in human osteosarcoma

Cell biology international, 2014-12, Vol.38 (12), p.1394-1402

2014

Volltextzugriff (PDF)

Overall survival benefits for irinotecan‐containing regimens as first‐line treatment for advanced gastric cancer: An updated meta‐analysis of ten randomized controlled trials

International journal of cancer, 2013-01, Vol.132 (2), p.E66-E73

2013

Volltextzugriff (PDF)

The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis

PloS one, 2015-08, Vol.10 (8), p.e0136374-e0136374

2015

Volltextzugriff (PDF)

Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials

Current medical research and opinion, 2013-02, Vol.29 (2), p.117-125

2013

Volltextzugriff (PDF)

Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis

Asian Pacific journal of cancer prevention : APJCP, 2012-01, Vol.13 (10), p.5177-5182

2012

Volltextzugriff (PDF)

Continuous-infusion Ifosfamide and Doxorubicin Combination as Second-Line Chemotherapy for Recurrent or Refractory Osteosarcoma Patients in China: a Retrospective Study

Asian Pacific journal of cancer prevention : APJCP, 2015-04, Vol.16 (6), p.2391-2395

2015

Volltextzugriff (PDF)

Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G~/M phase cell cycle arrest

中国药理学报：英文版, 2012-06, Vol.33 (6), p.832-838

Shui-er ZHENG Sang XlONG Feng LIN Guang-lei QIAO Tao FENG Zan SHEN Da-liu MIN Chun-ling ZHANG Yang YAO

2012

Volltextzugriff (PDF)

Point mutation of 5' noncoding region of BCL-6 gene in primary gastric lymphomas

World journal of gastroenterology : WJG, 2005-01, Vol.11 (1), p.51

2005

Volltextzugriff (PDF)

HGFK1 is Associated with a Better Prognostis and Reverses Inhibition by Gefitinib in NSCLC Cases

Asian Pacific journal of cancer prevention : APJCP, 2012-01, Vol.13 (4), p.1457-1461

2012

Volltextzugriff (PDF)

Soil Organic Carbon, Carbon Fractions and Nutrients as Affected by Land Use in Semi-Arid Region of Loess Plateau of China

Pedosphere, 2010-04, Vol.20 (2), p.146-152

2010

Volltextzugriff (PDF)

Continuous-infusion Ifosfamide and Doxorubicin Combination as Second-Line Chemotherapy for Recurrent or Refractory Osteosarcoma Patients in China: a Retrospective Study

Asian Pacific journal of cancer prevention : APJCP, 2015, Vol.16 (6), p.2391-2395

2015

Volltextzugriff (PDF)

HGFK1 is Associated with a Better Prognostis and Reverses Inhibition by Gefitinib in NSCLC Cases

Asian Pacific journal of cancer prevention : APJCP, 2012, Vol.13 (4), p.1457-1461

2012

Volltextzugriff (PDF)

Clarifications on Continuous Renal Replacement Therapy and Hemodynamics

Chinese medical journal, 2017-05, Vol.130 (10), p.1244-1248

2017

Volltextzugriff (PDF)

Comparison of the Efficacy and Safety of EFGR Tyrosine Kinase Inhibitor Monotherapy with Standard Second-line Chemotherapy in Previously Treated Advanced Non-small-cell Lung Cancer: a Systematic Review and Meta-analysis

Asian Pacific journal of cancer prevention : APJCP, 2012, Vol.13 (10), p.5177-5182

2012

Volltextzugriff (PDF)

Mutation analysis of hMSH2 and hMLH1 genes in Chinese hereditary nonpolyposis colorectal cancer families

Zhonghua bing li xue za zhi, 2003-08, Vol.32 (4), p.323

2003

Volltextzugriff (PDF)

1 – 25 von 360

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(269)
Mit Volltextzugriff
(332)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A novel flap design technique for subtotal tongue reconstruction with an “Individualized and Convenient Tongue Model”

Risk of venous thromboembolic events associated with VEGFR‐TKIs: A systematic review and meta‐analysis

Reconstruction of large defects of anterior floor of mouth with free flaps using a novel individualized flap design method

Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta‐analysis of clinical trials

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis

Upregulated miR‑20a‑5p expression promotes proliferation and invasion of head and neck squamous cell carcinoma cells by targeting of TNFRSF21

Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression

Pterostilbene suppresses human endometrial cancer cells in vitro by down-regulating miR-663b

Overall survival benefits for combining targeted therapy as second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of published data

Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells

p21-activated kinase 7 is an oncogene in human osteosarcoma

Overall survival benefits for irinotecan‐containing regimens as first‐line treatment for advanced gastric cancer: An updated meta‐analysis of ten randomized controlled trials

The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis

Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials

Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis

Continuous-infusion Ifosfamide and Doxorubicin Combination as Second-Line Chemotherapy for Recurrent or Refractory Osteosarcoma Patients in China: a Retrospective Study

Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G~/M phase cell cycle arrest

Point mutation of 5' noncoding region of BCL-6 gene in primary gastric lymphomas

HGFK1 is Associated with a Better Prognostis and Reverses Inhibition by Gefitinib in NSCLC Cases

Soil Organic Carbon, Carbon Fractions and Nutrients as Affected by Land Use in Semi-Arid Region of Loess Plateau of China

Continuous-infusion Ifosfamide and Doxorubicin Combination as Second-Line Chemotherapy for Recurrent or Refractory Osteosarcoma Patients in China: a Retrospective Study

HGFK1 is Associated with a Better Prognostis and Reverses Inhibition by Gefitinib in NSCLC Cases

Clarifications on Continuous Renal Replacement Therapy and Hemodynamics

Comparison of the Efficacy and Safety of EFGR Tyrosine Kinase Inhibitor Monotherapy with Standard Second-line Chemotherapy in Previously Treated Advanced Non-small-cell Lung Cancer: a Systematic Review and Meta-analysis

Mutation analysis of hMSH2 and hMLH1 genes in Chinese hereditary nonpolyposis colorectal cancer families

Aktive Filter

Suchergebnisse filtern